Literature DB >> 4451342

Studies on the absorption, distribution, metabolism, and excretion of propionylmaridomycin in rats.

T Matsuzawa, T Kondo, Y Kita.   

Abstract

The absorption, distribution, metabolism, and excretion of propionylmaridomycin was investigated in the rat by using [(14)C]propionylmaridomycin. Propionylmaridomycin was absorbed from the gastrointestinal tract at a relatively rapid rate and was readily distributed into tissues. Among the tissues examined, liver, kidney, and lung showed a remarkably higher level of the radioactivity than plasma, while distribution of the radioactivity into brain was little. However, a significant accumulation of the radioactivity in tissues was not observed. Excretion of the radioactivity was mainly via the fecal route and the high fecal recovery was accounted for by unabsorbed drug and biliary excretion of the drug and/or its metabolites. Tissue distribution of antimicrobial activity was also investigated and lung was found to show the highest antimicrobial activity among any tissues examined. Propionylmaridomycin was completely converted to several metabolites by the rat and the presence of at least three components was confirmed as biologically active metabolites. Of these metabolites, 4''-depropionyl-9-propionylmaridomycin was identified, which was the major metabolite in tissues, plasma, and urine.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451342      PMCID: PMC444720          DOI: 10.1128/AAC.6.6.685

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Maridomycin, a new macrolide antibiotic. 8. Isolation and structures of metabolites of 9-propionylmaridomycin.

Authors:  M Muroi; M Izawa; T Kishi
Journal:  J Antibiot (Tokyo)       Date:  1974-06       Impact factor: 2.649

2.  [New antibiotics, Josamycin. VI. Study on absorption and distribution of Josamycin].

Authors:  K Kuriaki; T Sado; K Sano; H Sasaki; Y Shiobara
Journal:  Jpn J Antibiot       Date:  1969-06

3.  Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions.

Authors:  J L Potter; L W Matthews; S Spector; J Lemm
Journal:  Pediatrics       Date:  1965-11       Impact factor: 7.124

4.  A study of the behavior of propionyl erythromycin in blood by a new chromatographic method.

Authors:  V C Stephens; C T Pugh; N E Davis; M M Hoehn; S Ralston
Journal:  J Antibiot (Tokyo)       Date:  1969-11       Impact factor: 2.649

5.  Maridomycin, a new macrolide antibiotic. VII. Incorporation of labeled precursors into maridomycin and preparation of 14C-labeled 9-propionylmaridomycin.

Authors:  H Ono; S Harada; T Kishi
Journal:  J Antibiot (Tokyo)       Date:  1974-06       Impact factor: 2.649

6.  Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin.

Authors:  M Kondo; K Ishifuji; K Tsuchiya; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

7.  Maridomycin, a new macrolide antibiotic. In vitro antibacterial activity of 9-propionylmaridomycin.

Authors:  M Kondo; T Oishi; K Tsuchiya; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

8.  Chemical modification of maridomycin, a new macrolide antibiotic.

Authors:  S Harada; M Muroi; M Kondo; K Tsuchiya; T Matsuzawa
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.